ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02112916
Brief Title: Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma

First Submitted : April 9, 2014
First Submitted that Met QC Criteria : April 9, 2014
First Posted : April 14, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : June 11, 2018
Last Update Posted : June 12, 2018